Obesity, venous capacitance, and venous compliance in heart failure with preserved ejection fraction
- PMID: 34053158
- DOI: 10.1002/ejhf.2254
Obesity, venous capacitance, and venous compliance in heart failure with preserved ejection fraction
Abstract
Aims: Circulating blood volume is functionally divided between the unstressed volume, which fills the vascular space, and stressed blood volume (SBV), which generates vascular wall tension and intravascular pressure. With decreases in venous capacitance, blood functionally shifts to the SBV, increasing central venous pressure and pulmonary venous pressures. Obesity is associated with both elevated venous pressure and heart failure with preserved ejection fraction (HFpEF). To explore the mechanisms underlying this association, we evaluated relationships between blood volume distribution, venous compliance, and body mass in patients with and without HFpEF.
Methods and results: Subjects with HFpEF (n = 62) and non-cardiac dyspnoea (NCD) (n = 79) underwent invasive haemodynamic exercise testing with echocardiography. SBV was estimated (eSBV) from measured haemodynamic variables fit to a comprehensive cardiovascular model. Compared to NCD, patients with HFpEF displayed a leftward-shifted central venous pressure-dimension relationship, indicating reduced venous compliance. eSBV was 81% higher at rest and 69% higher during exercise in HFpEF than NCD (both P < 0.0001), indicating reduced venous capacitance. Despite greater augmented eSBV with exercise, the increase in cardiac output was reduced in HFpEF, suggesting operation on the plateau of the Starling curve. Exercise eSBV was directly correlated with higher body mass index (r = 0.77, P < 0.0001) and inversely correlated with right ventricular-pulmonary arterial coupling (r = -0.57, all P < 0.0001).
Conclusions: Patients with HFpEF display reductions in systemic venous compliance and increased eSBV related to reduced venous capacitance, abnormalities in right ventricular-pulmonary artery interaction, and increased body fat. These data provide new evidence supporting an important role of venous dysfunction in obesity-related HFpEF and suggest that therapies that improve venous function may hold promise to improve clinical status in this cohort.
Keywords: Heart failure; Heart failure with preserved ejection fraction; Obesity; Venous compliance; Venous function.
© 2021 European Society of Cardiology.
Comment in
-
The right side of the circulation in not secondary heart failure with preserved ejection fraction: an elephant in the room?Eur J Heart Fail. 2021 Oct;23(10):1659-1661. doi: 10.1002/ejhf.2294. Epub 2021 Jul 16. Eur J Heart Fail. 2021. PMID: 34231304 No abstract available.
-
Sex, fat and the heart: it's all in the waist.Eur J Heart Fail. 2022 Aug;24(8):1371-1376. doi: 10.1002/ejhf.2615. Epub 2022 Jul 19. Eur J Heart Fail. 2022. PMID: 35810460 No abstract available.
Similar articles
-
Dapagliflozin Enhances Arterial and Venous Compliance During Exercise in Heart Failure With Preserved Ejection Fraction: Insights From the CAMEO-DAPA Trial.Circulation. 2024 Sep 24;150(13):997-1009. doi: 10.1161/CIRCULATIONAHA.124.068788. Epub 2024 Aug 5. Circulation. 2024. PMID: 39101201 Clinical Trial.
-
Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction.Circulation. 2017 Jul 4;136(1):6-19. doi: 10.1161/CIRCULATIONAHA.116.026807. Epub 2017 Apr 5. Circulation. 2017. PMID: 28381470 Free PMC article.
-
Arterial Stiffening With Exercise in Patients With Heart Failure and Preserved Ejection Fraction.J Am Coll Cardiol. 2017 Jul 11;70(2):136-148. doi: 10.1016/j.jacc.2017.05.029. J Am Coll Cardiol. 2017. PMID: 28683960 Free PMC article. Clinical Trial.
-
Prognostic and diagnostic implications of impaired rest and exercise-stress left atrial compliance in heart failure with preserved ejection fraction: Insights from the HFpEF stress trial.Int J Cardiol. 2024 Jun 1;404:131949. doi: 10.1016/j.ijcard.2024.131949. Epub 2024 Mar 11. Int J Cardiol. 2024. PMID: 38471649 Review.
-
Regional adiposity and heart failure with preserved ejection fraction.Eur J Heart Fail. 2020 Sep;22(9):1540-1550. doi: 10.1002/ejhf.1956. Epub 2020 Aug 5. Eur J Heart Fail. 2020. PMID: 32619081 Free PMC article. Review.
Cited by
-
Heart failure: an update from the last years and a look at the near future.ESC Heart Fail. 2022 Dec;9(6):3667-3693. doi: 10.1002/ehf2.14257. ESC Heart Fail. 2022. PMID: 36546712 Free PMC article. Review.
-
Pulmonary artery wedge pressure and left ventricular end-diastolic pressure during exercise in patients with dyspnoea.ERJ Open Res. 2023 Sep 4;9(4):00750-2022. doi: 10.1183/23120541.00750-2022. eCollection 2023 Jul. ERJ Open Res. 2023. PMID: 37670852 Free PMC article.
-
Long-term Changes in Body Composition and Exercise Capacity Following Calorie Restriction and Exercise Training in Older Patients with Obesity and Heart Failure With Preserved Ejection Fraction.J Card Fail. 2025 Mar;31(3):497-507. doi: 10.1016/j.cardfail.2024.06.007. Epub 2024 Jul 4. J Card Fail. 2025. PMID: 38971299 Clinical Trial.
-
Elucidating the Clinical Implications and Pathophysiology of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Call to Action: A Science Advisory From the American Heart Association.Circulation. 2022 Aug 16;146(7):e73-e88. doi: 10.1161/CIR.0000000000001079. Epub 2022 Jul 11. Circulation. 2022. PMID: 35862198 Free PMC article. Review.
-
Abdominal Obesity Is Associated with an Increased Risk of All-Cause Mortality in Males but Not in Females with HFpEF.Cardiovasc Ther. 2022 Apr 9;2022:2950055. doi: 10.1155/2022/2950055. eCollection 2022. Cardiovasc Ther. 2022. PMID: 35586579 Free PMC article.
References
-
- Pfeffer MA, Shah AM, Borlaug BA. Heart failure with preserved ejection fraction in perspective. Circ Res 2019;124:1598-1617.
-
- Shah SJ, Borlaug BA, Kitzman DW, McCulloch AD, Blaxall BC, Agarwal R, Chirinos JA, Collins S, Deo RC, Gladwin MT, Granzier H, Hummel SL, Kass DA, Redfield MM, Sam F, Wang TJ, Desvigne-Nickens P, Adhikari BB. Research priorities for heart failure with preserved ejection fraction: National Heart, Lung, and Blood Institute Working Group Summary. Circulation 2020;141:1001-1026.
-
- Obokata M, Reddy YN, Pislaru SV, Melenovsky V, Borlaug BA. Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction. Circulation 2017;136:6-19.
-
- Reddy YNV, Lewis GD, Shah SJ, Obokata M, Abou-Ezzedine OF, Fudim M, Sun JL, Chakraborty H, McNulty S, LeWinter MM, Mann DL, Stevenson LW, Redfield MM, Borlaug BA. Characterization of the obese phenotype of heart failure with preserved ejection fraction: a RELAX trial ancillary study. Mayo Clin Proc 2019;94:1199-1209.
-
- Reddy YNV, Obokata M, Testani JM, Felker GM, Tang WHW, Abou-Ezzedine OF, Sun JL, Chakrabothy H, McNulty S, Shah SJ, Lewis GD, Stevenson LW, Redfield MM, Borlaug BA. Adverse renal response to decongestion in the obese phenotype of heart failure with preserved ejection fraction. J Card Fail 2020;26:101-107.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical